Abbvie Ireland NL B.V.

AbbVie Ireland N L B.V. is the Irish arm of a global biopharmaceutical organisation dedicated to discovering and delivering innovative medicines that improve patients' lives. Drawing on a robust research and development pipeline, AbbVie focuses on breakthrough treatments across a range of therapeutic areas, including neuroscience, oncology and rare diseases such as Parkinson's. By collaborating with more than 250 external innovation partners, the company accelerates scientific discovery and brings novel therapies from the laboratory to the clinic.

Beyond drug development, AbbVie places patients at the centre of its work, offering support programmes and sharing real-world stories that inspire its research agenda. The business also invests heavily in its people, providing learning and development opportunities, functional training and leadership programmes to foster a culture of curiosity and problem-solving. Sustainability and responsible governance are integral to its strategy, with clear targets for reducing greenhouse-gas emissions and delivering lasting social impact. Through science, partnership and a patient-first ethos, AbbVie Ireland N L B.V. strives to turn scientific possibilities into tangible health benefits for people across Ireland and beyond.